Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Assets Average (2016 - 2025)

Historic Assets Average for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to $47.1 million.

  • Fennec Pharmaceuticals' Assets Average fell 2289.04% to $47.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $47.1 million, marking a year-over-year decrease of 2289.04%. This contributed to the annual value of $35.9 million for FY2024, which is 3346.84% up from last year.
  • According to the latest figures from Q3 2025, Fennec Pharmaceuticals' Assets Average is $47.1 million, which was down 2289.04% from $45.6 million recorded in Q2 2025.
  • In the past 5 years, Fennec Pharmaceuticals' Assets Average registered a high of $66.2 million during Q2 2024, and its lowest value of $17.4 million during Q2 2022.
  • In the last 5 years, Fennec Pharmaceuticals' Assets Average had a median value of $28.3 million in 2021 and averaged $35.0 million.
  • Per our database at Business Quant, Fennec Pharmaceuticals' Assets Average tumbled by 3793.89% in 2022 and then soared by 22079.6% in 2024.
  • Over the past 5 years, Fennec Pharmaceuticals' Assets Average (Quarter) stood at $27.1 million in 2021, then grew by 5.96% to $28.7 million in 2022, then dropped by 18.33% to $23.4 million in 2023, then soared by 121.74% to $51.9 million in 2024, then fell by 9.37% to $47.1 million in 2025.
  • Its Assets Average was $47.1 million in Q3 2025, compared to $45.6 million in Q2 2025 and $45.7 million in Q1 2025.